Completed NA INTERVENTIONAL 2-arm NCT01650025

Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90° (VAIIO)

Effects of the Probiotic Preparation VSL#3 on the Metabolic, Endocrine, Lipidomic and Inflammatory Parameters as Well as Variation of the Microbiota in Pediatric Patients With Body Mass Index >90°

Sponsor: Bambino Gesù Hospital and Research Institute

Conditions Obesity

Interventions VSL#3 active probiotic VSL#3 placebo

Updated 6 times since 2017 Last updated: Jan 30, 2017 Started: Aug 31, 2012 Primary completion: Aug 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Obesity, this trial is completed. The trial is conducted by Bambino Gesù Hospital and Research Institute and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bambino Gesù Hospital and Research Institute

Data source: Bambino Gesù Hospital and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy